THE NEW TEST — Nucleic acid amplification tests are the standard for detection of STIs in the genital tract, but they require complex laboratory equipment. The Visby Medical Women's Sexual Health Test is a single-use polymerase chain reaction (PCR) diagnostic test. It includes a vaginal swab for collection and a powered testing device. The testing device displays the results in about 30 minutes. A second test may be required if the device indicates that the results are invalid. At-home tests that require the sample be sent to a laboratory usually take about 3-5 days for results to be delivered, which could delay treatment.1 Individuals who have a positive result for any of the 3 STIs or have symptoms despite a negative test result should contact their healthcare provider. The cost of the Visby Medical Women's Sexual Health Test is not yet available. 

CLINICAL STUDIES — In 1555 women 14-80 years old, 98.5% of women with or without symptoms who used the test had an accurate result on the first or second test. The device had a sensitivity and specificity, respectively, of 97.6% and 98.3% for C. trachomatis, 97.4% and 99.4% for N. gonorrhoeae, and 99.2% and 96.9% for T. vaginalis.2 

CONCLUSION — The Visby Medical Women's Sexual Health Test, the first completely at-home test for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections, offers a convenient, effective, and rapid alternative to diagnostic tests that must be sent to a laboratory.